SlideShare uma empresa Scribd logo
1 de 21
Baixar para ler offline
epl.health
340B ESP Overview from a
Participating CE
Ryan DiGiovanni, PharmD, 340B ACE
ryan_digiovanni@rush.edu
01/18/2023
epl.health
Disclaimer
Nothing in this presentation should be interpreted as legal advice. Materials and discussion are intended to help
organizations understand the current 340B landscape to help ask the right questions with their legal counsel and
steering committees.
Information provided in these slides is subject to change.
epl.health
Bio
Ryan DiGiovanni – PharmD, 340B ACE
Founder - EPL Health
• Build and support 340B compliance & operations
for covered entities (CE)
• Entities we serve: FQHC, FQHC-LA, DSH, CAH,
RW Clinics
340B Manager- Rush University Health System
• 2 Disproportionate Share Hospital (DSH)
• 1 Hemophilia Treatment Center (HTC)
• 700+ Contract Pharmacy
• 3 Third Party Administrators
340B Satellite Office
340B
Coordinator
Expansion &
Growth
All Vendor
Management
Compliance &
Audit
Consolidated
Reporting
epl.health
Contents
• Resource Links
• Overview
• CHC Affected Manufacturers
• Process
• Impact & Considerations
• Pros/Cons
• Useful Tips
epl.health
Overview
• In 2020 Eli Lilly began restricting 340B pricing, reporting a need to
monitor for ‘Duplicate Discount’
• Current Manufacturers (mfgs) restricting 340B: 19
• Mfg Pharmacy Arrangements:
• 16 require submission of contract pharmacy dispensing
• 13 allow for 1 pharmacy designation (if no entity-owned pharmacy)
• 12 allow ‘wholly owned exemption’ of designation of CE-owned pharmacies
• 6 allow for ‘Attestation’ across all participating contract pharmacies for
universal approval.
epl.health
Overview
• 340B ESP collects 340B claims data dispensed at contract
pharmacy
• Transmits claims data to participating mfg
• Mfg use data to identify potential Medicaid and Commercial duplicate
discounts
• Lots of litigation currently underway.
• NACHC letter
epl.health
Litigation
Source: 340B Health
epl.health
340B ESP & CHC
Full view: 340B ESP Tool
MFG Name MFG Policy
CHC Need to
Submit Claims Effective Date Lookback Limits
Bausch Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 8/1/2022 within 45 days of the date of dispense
Boehringer Ingelheim Hospitals must apply for limited exceptions to mfg restrictions Y 8/1/2021 within 45 days of the date of dispense
Bristol Meyers Squibb Hospitals must apply for limited exceptions to mfg restrictions N 3/1/2022
Eli Lilly Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 12/16/2021 within 45 days of the date of dispense
Gilead Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 5/2/2022 within 45 days of the date of dispense
Merck Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 9/1/2021 within 45 days of the date of dispense
Sanofi Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 10/1/2020 within 45 days of the date of dispense
United Therapeutics Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 12/1/2021
epl.health
Process for claim submission
• Covered entities are expected to upload data twice per month
• 9 data elements suggested, 7 elements required
• 340B Covered Entity ID*
• Rx Number*
• Date Written*
• Fill Date*
• National Drug Code (NDC)*
• Quantity*
• Pharmacy NPI*
• Prescriber NPI
• Wholesaler Invoice Number
• Most TPAs have 340B ESP specific reports now
epl.health
Data Submission
Process
https://www.loom.com/share/a9e97e83c7a847f0b4ccbe5
c75f8e92f
1. Download each TPA/contract pharmacy
report with required fields
1. Can upload all NDC’s. only participating
NDCs will be selected/submitted to ESP
2. Upload and create a column mapping
template for each unique report
3. Save submitted files with naming
conventions that have claims date
range
4. Uplaod all documents to ESP before
submitting
5. Review submission for any identified
errors. Delete, edit and reupload error
files.
1. Spaces after numbers
2. Dashes
epl.health
Impact
• Financial: Increased 340B
Net Savings by 43%
compared to non-ESP
submission months in CY
2022
• Med Access: Restored multi-
pharmacy charity care access
program
• Resource Commitment: <0.5
FTE additional time/resource
requirement
epl.health
Considerations
• CE health benefit plan will lose commercial rebates back on 340B eligible
claims
• CE charity care program established at multiple contract pharmacies
• Resources/manual work
• 2-3 weeks pre-submission/1st submission
• ~1 hour per claim submission
• ~1-3 hours per ad-hoc ESP inquiry (2 per month on average)
• HIPPA permissible. A CE may disclose PHI:
• for its own treatment, payment, or health care operations
• To another CE or health care provider for payment activities of the entity that receives
the information
epl.health
Considerations
• CE Protections in place?
• State discriminatory
reimbursement laws
• **Not a comprehensive list**
Arkansas, Georgia, Illinois,
Indiana, Kansas, Kentucky,
Minnesota, Montana, North
Dakota, Ohio, Oregon, South
Carolina, South Dakota,
Tennessee, Utah, Vermont,
and West Virginia
epl.health
340B ESP Pros
• FQHC’s recouping close to 75% of pre-restriction savings
• Majority of TPAs now creating 340B ESP submission
• 340B ESP custom mapping feature reduces manual work
• Latest portal update allows for CE-driven reporting
epl.health
340B ESP Cons
• Initial claim submissions can be a challenge for entities/TPAs to
produce
• The ‘Chicken and the Egg’ scenario
• The ‘45 day’ rule
• Delays in turning/maintaining 340B pricing
• Inconsistent ‘340B eligibility status’ vs loaded catalog price
• Customer support knowledge of 340B operations is lacking
• Faulty flagging
epl.health
340B ESP Cons: Flagging
340B ESP Flagging System algorithm:
1. Assess volume of qualified claims vs 340B purchases over 30
day period
a. IF purchases > qualified claim volume THEN pharmacy is flagged as
‘at-risk’
1. ESP may inquire for claims of affected NDCs
a. IF CE does not comply or produce satisfactory claims THEN
pharmacy may be deemed ‘Ineligible’ and pricing removed
epl.health
Tips: Designation/Exemption
Designating a pharmacy
• DO NOT NEED TO PICK THE SAME PHARMACY FOR EACH MFG
• Recoupment Analysis
• Total volume across all mfg NDC
• Contribution margin by mfg
• Include Dispense Fees
• Bargaining chip
• Self-pay/Charity Care participation
• Re-negotiation of dispensing fee terms
Wholly-owned exemption
• Ability for CE-affiliated ‘contract pharmacies’
• Apply for HIN (wholly owned exemption/CP designation)
• Cardinal/ABC – should already have one
• McKesson – will need to apply
• Hospital/grantee can also exempt contract pharmacies with proof of ownership docs*
• Johnson & Johnson stipulates that the wholly-owned pharmacies must be non-profit*
• Proof of ownership docs: Certificate of Liability, W-9 form
epl.health
Tips: Before Claim Submit
• Quantify Value
• TPA reports to predict future claims and impact
• Get 340B wholesaler purchase reports
• Gather pharmacy NPIs
• Ensure current NDC holds/exclusions still allow for
accumulation with TPA
epl.health
Tips: 1st Claim Submit
• Will take up to 18 business days for 340B pricing to be turned
on with wholesalers
• Inquire with TPA on ability to produce impact report that
incorporates lookback
• Pay special attention to mfg that mandate 45 days & those that don’t!
• Create mapping template for each unique report you are
submitting
epl.health
Tips: Maintenance Claim Submit
• Consistent submission days
(1st & 15th every month)
• Keep claim submission
records
• Write dates in naming
convention
• Track each mfg:
• At your wholesaler, for every CP
purchasing account for pricing
updates
• In your TPA, ensure qualifying
and ordering
epl.health
Resource Links
Overview of Mfg restrictions and effected NDCs
• 340B ESP Tool
Detailed Mfg Policies
• ESP Participating Mfg Policies
Wholly-owned Exemption or Single Contract Pharmacy Designation?
• Obtaining HIN
Recoupment Analysis
• 340B PVP Price File
• NDC List

Mais conteúdo relacionado

Semelhante a 2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE

Navigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatricNavigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatricCompliatric Where Compliance Happens
 
Translating compliance requirements into action items 340B
Translating compliance requirements into action items 340BTranslating compliance requirements into action items 340B
Translating compliance requirements into action items 340BCompliatric
 
Identifying & resolving 340b duplicate discounts Kalderos
Identifying & resolving 340b duplicate discounts Kalderos Identifying & resolving 340b duplicate discounts Kalderos
Identifying & resolving 340b duplicate discounts Kalderos stevenzielinski1
 
The 340B Program and Implications of the Mega Guidance
The 340B Program and Implications of the Mega GuidanceThe 340B Program and Implications of the Mega Guidance
The 340B Program and Implications of the Mega GuidanceCompleteRx
 
Rx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramseyRx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramseyOPUNITE
 
Compliance Today article March 2015
Compliance Today article March 2015Compliance Today article March 2015
Compliance Today article March 2015Cristine Vogel
 
340B Discount Drug Program: Updates and Changes Affecting Contract Pharmacies�
340B Discount Drug Program: Updates and Changes Affecting Contract Pharmacies�340B Discount Drug Program: Updates and Changes Affecting Contract Pharmacies�
340B Discount Drug Program: Updates and Changes Affecting Contract Pharmacies�Quarles & Brady
 
The Medical Advantage, Inc. - EMR & Meaningful Use
The Medical Advantage, Inc. - EMR & Meaningful UseThe Medical Advantage, Inc. - EMR & Meaningful Use
The Medical Advantage, Inc. - EMR & Meaningful UseWalz Group, LLC.
 
340B Drug Pricing Under the Microscope
340B Drug Pricing Under the Microscope340B Drug Pricing Under the Microscope
340B Drug Pricing Under the MicroscopePolsinelli PC
 
The Medical Advantage MU v2 Quick Pitch
The Medical Advantage MU v2   Quick PitchThe Medical Advantage MU v2   Quick Pitch
The Medical Advantage MU v2 Quick PitchJan S. Belmont-French
 
Program Overview and Prepare to Review Reported Data
Program Overview and Prepare to Review Reported DataProgram Overview and Prepare to Review Reported Data
Program Overview and Prepare to Review Reported DataMarket iT
 
Concerns Persist about the 340B Program
Concerns Persist about the 340B ProgramConcerns Persist about the 340B Program
Concerns Persist about the 340B ProgramNan Myers
 
340 b presentation 5.31.13
340 b presentation 5.31.13340 b presentation 5.31.13
340 b presentation 5.31.13Michol Bobb
 
Wc19 julie johnston capture rx
Wc19 julie johnston capture rxWc19 julie johnston capture rx
Wc19 julie johnston capture rxMitchell Sullivan
 
AAMI_HITECH MU: Impact on the Future of HC IT
AAMI_HITECH MU:  Impact on the Future of HC ITAAMI_HITECH MU:  Impact on the Future of HC IT
AAMI_HITECH MU: Impact on the Future of HC ITAmy Stowers
 
Meaningful Use: The Fine Print
Meaningful Use: The Fine PrintMeaningful Use: The Fine Print
Meaningful Use: The Fine PrintQualifacts
 
Amy walker aami_%202011(7)
Amy walker aami_%202011(7)Amy walker aami_%202011(7)
Amy walker aami_%202011(7)Amy Stowers
 

Semelhante a 2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE (20)

Navigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatricNavigating manufacturer designations for 340 b contract pharmacies compliatric
Navigating manufacturer designations for 340 b contract pharmacies compliatric
 
Translating compliance requirements into action items 340B
Translating compliance requirements into action items 340BTranslating compliance requirements into action items 340B
Translating compliance requirements into action items 340B
 
Translating compliance requirements into action items 340B
Translating compliance requirements into action items 340BTranslating compliance requirements into action items 340B
Translating compliance requirements into action items 340B
 
Identifying & resolving 340b duplicate discounts Kalderos
Identifying & resolving 340b duplicate discounts Kalderos Identifying & resolving 340b duplicate discounts Kalderos
Identifying & resolving 340b duplicate discounts Kalderos
 
Meaningful use 2015
Meaningful use 2015Meaningful use 2015
Meaningful use 2015
 
The 340B Program and Implications of the Mega Guidance
The 340B Program and Implications of the Mega GuidanceThe 340B Program and Implications of the Mega Guidance
The 340B Program and Implications of the Mega Guidance
 
Rx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramseyRx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramsey
 
Compliance Today article March 2015
Compliance Today article March 2015Compliance Today article March 2015
Compliance Today article March 2015
 
340B Discount Drug Program: Updates and Changes Affecting Contract Pharmacies�
340B Discount Drug Program: Updates and Changes Affecting Contract Pharmacies�340B Discount Drug Program: Updates and Changes Affecting Contract Pharmacies�
340B Discount Drug Program: Updates and Changes Affecting Contract Pharmacies�
 
The Medical Advantage, Inc. - EMR & Meaningful Use
The Medical Advantage, Inc. - EMR & Meaningful UseThe Medical Advantage, Inc. - EMR & Meaningful Use
The Medical Advantage, Inc. - EMR & Meaningful Use
 
340B Drug Pricing Under the Microscope
340B Drug Pricing Under the Microscope340B Drug Pricing Under the Microscope
340B Drug Pricing Under the Microscope
 
The Medical Advantage MU v2 Quick Pitch
The Medical Advantage MU v2   Quick PitchThe Medical Advantage MU v2   Quick Pitch
The Medical Advantage MU v2 Quick Pitch
 
Program Overview and Prepare to Review Reported Data
Program Overview and Prepare to Review Reported DataProgram Overview and Prepare to Review Reported Data
Program Overview and Prepare to Review Reported Data
 
Concerns Persist about the 340B Program
Concerns Persist about the 340B ProgramConcerns Persist about the 340B Program
Concerns Persist about the 340B Program
 
340 b presentation 5.31.13
340 b presentation 5.31.13340 b presentation 5.31.13
340 b presentation 5.31.13
 
Wc19 julie johnston capture rx
Wc19 julie johnston capture rxWc19 julie johnston capture rx
Wc19 julie johnston capture rx
 
Meaningful use and Electronic Health Records
Meaningful use and Electronic Health RecordsMeaningful use and Electronic Health Records
Meaningful use and Electronic Health Records
 
AAMI_HITECH MU: Impact on the Future of HC IT
AAMI_HITECH MU:  Impact on the Future of HC ITAAMI_HITECH MU:  Impact on the Future of HC IT
AAMI_HITECH MU: Impact on the Future of HC IT
 
Meaningful Use: The Fine Print
Meaningful Use: The Fine PrintMeaningful Use: The Fine Print
Meaningful Use: The Fine Print
 
Amy walker aami_%202011(7)
Amy walker aami_%202011(7)Amy walker aami_%202011(7)
Amy walker aami_%202011(7)
 

Mais de Compliatric Where Compliance Happens

2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...Compliatric Where Compliance Happens
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdfCompliatric Where Compliance Happens
 
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...Compliatric Where Compliance Happens
 
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdfCompliatric Where Compliance Happens
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdfCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...Compliatric Where Compliance Happens
 
Contracts and Memorandums of Understanding - Requirements and Responsibilities
Contracts and Memorandums of Understanding - Requirements and ResponsibilitiesContracts and Memorandums of Understanding - Requirements and Responsibilities
Contracts and Memorandums of Understanding - Requirements and ResponsibilitiesCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdfCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdfCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdfCompliatric Where Compliance Happens
 
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdfCompliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdfCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...Compliatric Where Compliance Happens
 
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptxCompliatric Where Compliance Happens
 
2023 Compliatric Webinar Series - The Basics of Disaster Preparedness.pdf
2023 Compliatric Webinar Series - The Basics of Disaster Preparedness.pdf2023 Compliatric Webinar Series - The Basics of Disaster Preparedness.pdf
2023 Compliatric Webinar Series - The Basics of Disaster Preparedness.pdfCompliatric Where Compliance Happens
 

Mais de Compliatric Where Compliance Happens (20)

2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
 
2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf
2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf
2024 Compliatric Webinar Series - Protecting LGBTQ Patients.pdf
 
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
2024 Compliatric Webinar Series - Next-Gen Compliance- Leveraging OIG's Recen...
 
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
2024 Compliatric Webinar Series - Components of a Needs Assessment.pdf
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion.pdf
 
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
2023 Compliatric Webinar Series - Unveiling the Blueprint_ The Components of ...
 
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
2023 Compliatric Webinar Series - Contracts and Memorandums of Understanding ...
 
Contracts and Memorandums of Understanding - Requirements and Responsibilities
Contracts and Memorandums of Understanding - Requirements and ResponsibilitiesContracts and Memorandums of Understanding - Requirements and Responsibilities
Contracts and Memorandums of Understanding - Requirements and Responsibilities
 
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
2023 Compliatric Webinar Series - Making the Most out of the Sliding Fee Prog...
 
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
2023 Compliatric Webinar Series - Developing Strong Board and CEO Relationshi...
 
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
2023 Compliatric Webinar Series - Overview of CARF Accreditation.pdf
 
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
2023 Compliatric Webinar Series - Are You Ready for an OSHA Inspection.pdf
 
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
2023 Compliatric Webinar Series - Good Faith Estimates_Don't Let the No Surpr...
 
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
2023 Compliatric Webinar Series - Your Accreditation Journey - Challenges Alo...
 
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
2023 Compliatric Webinar Series - Active Shooter Training and Exercises.pdf
 
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdfCompliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
Compliatric Webinar Your Accreditation Journey Best Path Forward 7.25.2023.pdf
 
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
2023 Compliatric Webinar Series - Developing a Pathway for Promotion & Leader...
 
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
2023 Compliatric Webinar Series Strategic Planning Webinar 06_20_2023.pptx
 
2023 Compliatric Webinar Series - The Basics of Disaster Preparedness.pdf
2023 Compliatric Webinar Series - The Basics of Disaster Preparedness.pdf2023 Compliatric Webinar Series - The Basics of Disaster Preparedness.pdf
2023 Compliatric Webinar Series - The Basics of Disaster Preparedness.pdf
 

Último

Unlocking the Mysteries of the Lymphatic System
Unlocking the Mysteries of the Lymphatic SystemUnlocking the Mysteries of the Lymphatic System
Unlocking the Mysteries of the Lymphatic SystemSasikiranMarri
 
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...drphilspharmacy
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationpratiksha ghimire
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfSasikiranMarri
 
AI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of DataAI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of DataIris Thiele Isip-Tan
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Oleg Kshivets
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...mauryashreya478
 
AMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptxAMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptxDileepRedemption
 
The future of change - strategic translation
The future of change - strategic translationThe future of change - strategic translation
The future of change - strategic translationHelenBevan4
 
Discover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalDiscover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalA-dec Australia
 
20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health Support20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health SupportSayhey
 
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are HeardAdvance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are HeardVITASAuthor
 
Enhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionEnhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionNeighborhood Trainer
 
Emergency ambulance portal-PPT-3g2pqy.pptx
Emergency ambulance portal-PPT-3g2pqy.pptxEmergency ambulance portal-PPT-3g2pqy.pptx
Emergency ambulance portal-PPT-3g2pqy.pptxdragonaklevel7
 
Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?HelenBevan4
 
Incentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationIncentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationpratiksha ghimire
 
Presentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxPresentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxravisutar1
 
arpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and educationarpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and educationNursing education
 
The Rise of Telehealth in Weight Loss - Revolutionizing Health .pdf
The Rise of Telehealth in Weight Loss - Revolutionizing Health .pdfThe Rise of Telehealth in Weight Loss - Revolutionizing Health .pdf
The Rise of Telehealth in Weight Loss - Revolutionizing Health .pdfmodmd8654
 
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...Panchmukhi Air& Train Ambulance Services
 

Último (20)

Unlocking the Mysteries of the Lymphatic System
Unlocking the Mysteries of the Lymphatic SystemUnlocking the Mysteries of the Lymphatic System
Unlocking the Mysteries of the Lymphatic System
 
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentation
 
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdfUnderstanding Cholera: Epidemiology, Prevention, and Control.pdf
Understanding Cholera: Epidemiology, Prevention, and Control.pdf
 
AI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of DataAI in Pediatrics: Taking Baby Steps in the Big World of Data
AI in Pediatrics: Taking Baby Steps in the Big World of Data
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...
 
AMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptxAMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptx
 
The future of change - strategic translation
The future of change - strategic translationThe future of change - strategic translation
The future of change - strategic translation
 
Discover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalDiscover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa Dental
 
20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health Support20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health Support
 
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are HeardAdvance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
Advance Directives and Advance Care Planning: Ensuring Patient Voices Are Heard
 
Enhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionEnhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized Nutrition
 
Emergency ambulance portal-PPT-3g2pqy.pptx
Emergency ambulance portal-PPT-3g2pqy.pptxEmergency ambulance portal-PPT-3g2pqy.pptx
Emergency ambulance portal-PPT-3g2pqy.pptx
 
Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?
 
Incentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationIncentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentation
 
Presentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxPresentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptx
 
arpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and educationarpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and education
 
The Rise of Telehealth in Weight Loss - Revolutionizing Health .pdf
The Rise of Telehealth in Weight Loss - Revolutionizing Health .pdfThe Rise of Telehealth in Weight Loss - Revolutionizing Health .pdf
The Rise of Telehealth in Weight Loss - Revolutionizing Health .pdf
 
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
 

2023 Compliatric Webinar Series - 340B ESP Overview from a Participating CE

  • 1. epl.health 340B ESP Overview from a Participating CE Ryan DiGiovanni, PharmD, 340B ACE ryan_digiovanni@rush.edu 01/18/2023
  • 2. epl.health Disclaimer Nothing in this presentation should be interpreted as legal advice. Materials and discussion are intended to help organizations understand the current 340B landscape to help ask the right questions with their legal counsel and steering committees. Information provided in these slides is subject to change.
  • 3. epl.health Bio Ryan DiGiovanni – PharmD, 340B ACE Founder - EPL Health • Build and support 340B compliance & operations for covered entities (CE) • Entities we serve: FQHC, FQHC-LA, DSH, CAH, RW Clinics 340B Manager- Rush University Health System • 2 Disproportionate Share Hospital (DSH) • 1 Hemophilia Treatment Center (HTC) • 700+ Contract Pharmacy • 3 Third Party Administrators 340B Satellite Office 340B Coordinator Expansion & Growth All Vendor Management Compliance & Audit Consolidated Reporting
  • 4. epl.health Contents • Resource Links • Overview • CHC Affected Manufacturers • Process • Impact & Considerations • Pros/Cons • Useful Tips
  • 5. epl.health Overview • In 2020 Eli Lilly began restricting 340B pricing, reporting a need to monitor for ‘Duplicate Discount’ • Current Manufacturers (mfgs) restricting 340B: 19 • Mfg Pharmacy Arrangements: • 16 require submission of contract pharmacy dispensing • 13 allow for 1 pharmacy designation (if no entity-owned pharmacy) • 12 allow ‘wholly owned exemption’ of designation of CE-owned pharmacies • 6 allow for ‘Attestation’ across all participating contract pharmacies for universal approval.
  • 6. epl.health Overview • 340B ESP collects 340B claims data dispensed at contract pharmacy • Transmits claims data to participating mfg • Mfg use data to identify potential Medicaid and Commercial duplicate discounts • Lots of litigation currently underway. • NACHC letter
  • 8. epl.health 340B ESP & CHC Full view: 340B ESP Tool MFG Name MFG Policy CHC Need to Submit Claims Effective Date Lookback Limits Bausch Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 8/1/2022 within 45 days of the date of dispense Boehringer Ingelheim Hospitals must apply for limited exceptions to mfg restrictions Y 8/1/2021 within 45 days of the date of dispense Bristol Meyers Squibb Hospitals must apply for limited exceptions to mfg restrictions N 3/1/2022 Eli Lilly Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 12/16/2021 within 45 days of the date of dispense Gilead Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 5/2/2022 within 45 days of the date of dispense Merck Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 9/1/2021 within 45 days of the date of dispense Sanofi Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 10/1/2020 within 45 days of the date of dispense United Therapeutics Mandates 340B ESP submission of claims data to access 340B pricing at Contract Pharmacies Y 12/1/2021
  • 9. epl.health Process for claim submission • Covered entities are expected to upload data twice per month • 9 data elements suggested, 7 elements required • 340B Covered Entity ID* • Rx Number* • Date Written* • Fill Date* • National Drug Code (NDC)* • Quantity* • Pharmacy NPI* • Prescriber NPI • Wholesaler Invoice Number • Most TPAs have 340B ESP specific reports now
  • 10. epl.health Data Submission Process https://www.loom.com/share/a9e97e83c7a847f0b4ccbe5 c75f8e92f 1. Download each TPA/contract pharmacy report with required fields 1. Can upload all NDC’s. only participating NDCs will be selected/submitted to ESP 2. Upload and create a column mapping template for each unique report 3. Save submitted files with naming conventions that have claims date range 4. Uplaod all documents to ESP before submitting 5. Review submission for any identified errors. Delete, edit and reupload error files. 1. Spaces after numbers 2. Dashes
  • 11. epl.health Impact • Financial: Increased 340B Net Savings by 43% compared to non-ESP submission months in CY 2022 • Med Access: Restored multi- pharmacy charity care access program • Resource Commitment: <0.5 FTE additional time/resource requirement
  • 12. epl.health Considerations • CE health benefit plan will lose commercial rebates back on 340B eligible claims • CE charity care program established at multiple contract pharmacies • Resources/manual work • 2-3 weeks pre-submission/1st submission • ~1 hour per claim submission • ~1-3 hours per ad-hoc ESP inquiry (2 per month on average) • HIPPA permissible. A CE may disclose PHI: • for its own treatment, payment, or health care operations • To another CE or health care provider for payment activities of the entity that receives the information
  • 13. epl.health Considerations • CE Protections in place? • State discriminatory reimbursement laws • **Not a comprehensive list** Arkansas, Georgia, Illinois, Indiana, Kansas, Kentucky, Minnesota, Montana, North Dakota, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Utah, Vermont, and West Virginia
  • 14. epl.health 340B ESP Pros • FQHC’s recouping close to 75% of pre-restriction savings • Majority of TPAs now creating 340B ESP submission • 340B ESP custom mapping feature reduces manual work • Latest portal update allows for CE-driven reporting
  • 15. epl.health 340B ESP Cons • Initial claim submissions can be a challenge for entities/TPAs to produce • The ‘Chicken and the Egg’ scenario • The ‘45 day’ rule • Delays in turning/maintaining 340B pricing • Inconsistent ‘340B eligibility status’ vs loaded catalog price • Customer support knowledge of 340B operations is lacking • Faulty flagging
  • 16. epl.health 340B ESP Cons: Flagging 340B ESP Flagging System algorithm: 1. Assess volume of qualified claims vs 340B purchases over 30 day period a. IF purchases > qualified claim volume THEN pharmacy is flagged as ‘at-risk’ 1. ESP may inquire for claims of affected NDCs a. IF CE does not comply or produce satisfactory claims THEN pharmacy may be deemed ‘Ineligible’ and pricing removed
  • 17. epl.health Tips: Designation/Exemption Designating a pharmacy • DO NOT NEED TO PICK THE SAME PHARMACY FOR EACH MFG • Recoupment Analysis • Total volume across all mfg NDC • Contribution margin by mfg • Include Dispense Fees • Bargaining chip • Self-pay/Charity Care participation • Re-negotiation of dispensing fee terms Wholly-owned exemption • Ability for CE-affiliated ‘contract pharmacies’ • Apply for HIN (wholly owned exemption/CP designation) • Cardinal/ABC – should already have one • McKesson – will need to apply • Hospital/grantee can also exempt contract pharmacies with proof of ownership docs* • Johnson & Johnson stipulates that the wholly-owned pharmacies must be non-profit* • Proof of ownership docs: Certificate of Liability, W-9 form
  • 18. epl.health Tips: Before Claim Submit • Quantify Value • TPA reports to predict future claims and impact • Get 340B wholesaler purchase reports • Gather pharmacy NPIs • Ensure current NDC holds/exclusions still allow for accumulation with TPA
  • 19. epl.health Tips: 1st Claim Submit • Will take up to 18 business days for 340B pricing to be turned on with wholesalers • Inquire with TPA on ability to produce impact report that incorporates lookback • Pay special attention to mfg that mandate 45 days & those that don’t! • Create mapping template for each unique report you are submitting
  • 20. epl.health Tips: Maintenance Claim Submit • Consistent submission days (1st & 15th every month) • Keep claim submission records • Write dates in naming convention • Track each mfg: • At your wholesaler, for every CP purchasing account for pricing updates • In your TPA, ensure qualifying and ordering
  • 21. epl.health Resource Links Overview of Mfg restrictions and effected NDCs • 340B ESP Tool Detailed Mfg Policies • ESP Participating Mfg Policies Wholly-owned Exemption or Single Contract Pharmacy Designation? • Obtaining HIN Recoupment Analysis • 340B PVP Price File • NDC List